Quinton Fivelman
Directeur Technique/Scientifique/R&D chez London Medical Laboratory Ltd.
Profil
Quinton Fivelman is currently the Chief Scientific Officer at London Medical Laboratory Ltd.
He completed his undergraduate degree at the University of Cape Town and his doctorate at the London School of Hygiene & Tropical Medicine.
Postes actifs de Quinton Fivelman
| Sociétés | Poste | Début |
|---|---|---|
London Medical Laboratory Ltd.
 London Medical Laboratory Ltd. Medical/Nursing ServicesHealth Services London Medical Laboratory Ltd. operates as an independent clinical testing specialist and provides pathology diagnostics services. It offers tailor made clinical pathology diagnostic services to medical professionals, health care providers and patients. The firm also offers pathology testing solutions across disciplines including clinical biochemistry, immunology, haematology, sexual health screening and molecular biology. Its services include SARS-CoV-2 Swab PCR Swab Testing, SARS-CoV-2 Rapid Antigen Tests, SARS-CoV-2 IgG/IgM Antibody Testing, and Other Pathology Tests. The company was founded on November 4, 2016 and is headquartered in London, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Formation de Quinton Fivelman
| London School of Hygiene & Tropical Medicine | Doctorate Degree |
| University of Cape Town | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
London Medical Laboratory Ltd.
London Medical Laboratory Ltd. Medical/Nursing ServicesHealth Services London Medical Laboratory Ltd. operates as an independent clinical testing specialist and provides pathology diagnostics services. It offers tailor made clinical pathology diagnostic services to medical professionals, health care providers and patients. The firm also offers pathology testing solutions across disciplines including clinical biochemistry, immunology, haematology, sexual health screening and molecular biology. Its services include SARS-CoV-2 Swab PCR Swab Testing, SARS-CoV-2 Rapid Antigen Tests, SARS-CoV-2 IgG/IgM Antibody Testing, and Other Pathology Tests. The company was founded on November 4, 2016 and is headquartered in London, the United Kingdom. | Health Services |